Cargando…

A molecular approach combined with American Thyroid Association classification better stratifies recurrence risk of classic histology papillary thyroid cancer

BACKGROUND: Prognosis among patients with differentiated thyroid cancer is widely variable. Better understanding of biologic subtypes is necessary to stratify patients and improve outcomes. METHODS: In patients diagnosed with classic histology papillary thyroid cancer treated from 1973 to 2009, BRAF...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Alexander J., Samson, Pamela, DeWees, Todd, Henke, Lauren, Baranski, Thomas, Schwarz, Julie, Pfeifer, John, Grigsby, Perry, Markovina, Stephanie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Cancer Prevention
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346248/ https://www.ncbi.nlm.nih.gov/pubmed/30552739 http://dx.doi.org/10.1002/cam4.1857

Ejemplares similares

Long-term outcomes of follicular variant vs classic papillary thyroid carcinoma
por: Henke, Lauren E, et al.
Publicado: (2018)

BRAF mutation is not predictive of long-term outcome in papillary thyroid carcinoma
por: Henke, Lauren E, et al.
Publicado: (2015)

Risk factors for level V lymph node metastases in solitary papillary thyroid carcinoma with clinically lateral lymph node metastases
por: Yang, Jing, et al.
Publicado: (2016)

The association of obesity with thyroid carcinoma risk
por: Ma, Xiao‐Ni, et al.
Publicado: (2022)

Parity and thyroid cancer risk: a meta‐analysis of epidemiological studies
por: Zhu, Jingjing, et al.
Publicado: (2015)

Risk‐based breast cancer follow‐up stratified by age
por: Witteveen, Annemieke, et al.
Publicado: (2018)

The impact of marital status at diagnosis on cancer survival in patients with differentiated thyroid cancer
por: Shi, Rong‐liang, et al.
Publicado: (2016)

Thyroid dysfunction and breast cancer risk among women in the UK Biobank cohort
por: Tran, Thi‐Van‐Trinh, et al.
Publicado: (2021)

Primary squamous cell carcinomas in the thyroid gland: an individual participant data meta-analysis
por: Cho, Jae Keun, et al.
Publicado: (2014)

Decreasing trends in thyroid cancer incidence in South Korea: What happened in South Korea?
por: Oh, Chang‐Mo, et al.
Publicado: (2021)

Candidate microRNAs as biomarkers of thyroid carcinoma: a systematic review, meta‐analysis, and experimental validation
por: Hu, Yiren, et al.
Publicado: (2016)

Association between breast cancer and thyroid cancer: A study based on 13 978 patients with breast cancer
por: Huang, Nai‐si, et al.
Publicado: (2018)

Risk of thyroid as a first or second primary cancer. A population‐based study in Italy, 1998–2012
por: Crocetti, Emanuele, et al.
Publicado: (2021)

Risk of thyroid cancer in relation to height, weight, and body mass index in Japanese individuals: a population‐based cohort study
por: Sado, Junya, et al.
Publicado: (2018)

The global burden of thyroid cancer and its attributable risk factor in 195 countries and territories: A systematic analysis for the Global Burden of Disease Study
por: Zhai, Mimi, et al.
Publicado: (2021)

Racial difference in histologic subtype of renal cell carcinoma
por: Olshan, Andrew F, et al.
Publicado: (2013)

Genetic risk association of CDKN1A and RET gene SNPs with medullary thyroid carcinoma: Results from the largest MTC cohort and meta‐analysis
por: Mishra, Vasudha, et al.
Publicado: (2019)

Global, regional, and national burden and quality of care index (QCI) of thyroid cancer: A systematic analysis of the Global Burden of Disease Study 1990–2017
por: Azadnajafabad, Sina, et al.
Publicado: (2021)

Socioeconomic status and risk of lung cancer by histological subtype in the Nordic countries
por: Pizzato, Margherita, et al.
Publicado: (2022)

Blood prognostic predictors of treatment response for patients with papillary thyroid cancer
por: Liu, Xiangxiang, et al.
Publicado: (2020)

Identification of key genes of papillary thyroid carcinoma by integrated bioinformatics analysis
por: Xue, Gang, et al.
Publicado: (2020)

In silico DNA methylation analysis identifies potential prognostic biomarkers in type 2 papillary renal cell carcinoma
por: Yang, Man, et al.
Publicado: (2019)

Racial/ethnic disparities in renal cell carcinoma: Increased risk of early‐onset and variation in histologic subtypes
por: Batai, Ken, et al.
Publicado: (2019)

Radioactive Iodine Therapy Decreases Recurrence in Thyroid Papillary Microcarcinoma
por: Creach, Kimberly M., et al.
Publicado: (2012)

PBX3 hypermethylation in peripheral blood leukocytes predicts better prognosis in colorectal cancer: A propensity score analysis
por: Sun, Hongru, et al.
Publicado: (2019)

The incidence and survival of pancreatic cancer by histology, including rare subtypes: a nation‐wide cancer registry‐based study from Taiwan
por: Chang, Jeffrey S., et al.
Publicado: (2018)

Effects of marital status on survival of medullary thyroid cancer stratified by age
por: Ai, Lei, et al.
Publicado: (2021)

A Comparison of Clinicopathological Characteristics and Short-Term Outcome of Papillary Thyroid Carcinoma with Tall Cell Histology and Classic Papillary Thyroid Carcinoma: A Single-Institution Experience
por: Sampathkumar, Geethalakshmi, et al.
Publicado: (2018)

Hobnail variant of papillary thyroid carcinoma: molecular profiling and comparison to classical papillary thyroid carcinoma, poorly differentiated thyroid carcinoma and anaplastic thyroid carcinoma
por: Teng, Lianghong, et al.
Publicado: (2017)

Clinical outcomes and differential effects of PI3K pathway mutation in obese versus non-obese patients with cervical cancer
por: Grigsby, Perry, et al.
Publicado: (2017)

Effect of chronic lymphocytic thyroiditis on the efficacy and safety of ultrasound‐guided radiofrequency ablation for papillary thyroid microcarcinoma
por: Zhang, Yan, et al.
Publicado: (2019)

Multicentric occurrence of multiple papillary thyroid carcinomas –HUMARA and BRAF mutation analysis
por: Nakazawa, Tadao, et al.
Publicado: (2015)

Impact of Extranodal Extension on Risk Stratification in Papillary Thyroid Carcinoma
por: Kim, Hye In, et al.
Publicado: (2019)

Kinetic Analysis of Growth Activity in Enlarging Papillary Thyroid Microcarcinomas
por: Ito, Yasuhiro, et al.
Publicado: (2019)

Serum squamous cell carcinoma antigen as an early indicator of response during therapy of cervical cancer
por: Markovina, Stephanie, et al.
Publicado: (2018)

Ten‐year immune persistence and safety of the HPV‐16/18 AS04‐adjuvanted vaccine in females vaccinated at 15–55 years of age
por: Schwarz, Tino F., et al.
Publicado: (2017)

Patients' View on the Management of Papillary Thyroid Microcarcinoma: Active Surveillance or Surgery
por: Yoshida, Yusaku, et al.
Publicado: (2020)

Whole-Exome Sequencing of Matched Primary and Metastatic Papillary Thyroid Cancer
por: Masoodi, Tariq, et al.
Publicado: (2020)

Progression of Low-Risk Papillary Thyroid Microcarcinoma During Active Surveillance: Interim Analysis of a Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma in Korea
por: Lee, Eun Kyung, et al.
Publicado: (2022)

Demographic patterns of cutaneous T-cell lymphoma incidence in Texas based on two different cancer registries
por: Litvinov, Ivan V, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fuj6s8m57tkcvekn8nidscii3b